VIDO scientists receive $1M to strengthen mpox preparedness
Scientists Drs. Alyson Kelvin (PhD) and Angela Rasmussen (PhD) from the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO) have received $1-million in total funding to study mpox (formerly known as monkeypox) from the Canadian Institutes of Health Research (CIHR).
SHARE